DIRS.INFO The most relevant business & tech news

Poli Devi, whose 11-month-old daughter Janvi was among the children who died due to kidney injury after consuming contaminated cough syrup, holds a photo of her at their house in Ramnagar on the outskirts of Jammu, India, March 28, 2023. REUTERS/Anushree Fadnavis/File Photo Acquire Licensing RightsNEW DELHI, Oct 4 (Reuters) - India's drug regulator has found that a cough syrup and an anti-allergy syrup made by Norris Medicines (NORI.BO) are toxic, according to a government report, months after Indian-made cough syrups were linked to 141 children's deaths worldwide. Koshia said Norris used to export the cough syrup, but did not say where. "We are aware of the CDSCO report and have communicated with that agency to ascertain where the products... have been exported," said a WHO spokeswoman. The CDSCO also found three batches of COLD OUT syrup made by Fourrts (India) Laboratories contaminated with DEG and EG.

Persons: Poli Devi, Janvi, Anushree, Koshia, Norris's, Norris, Vimal Shah, S.V, Veeramani, Adani Wilmar, Krishna N, Jennifer Rigby, Andrew Heavens, Nick Macfie, William Maclean Organizations: REUTERS, Norris Medicines, Central Drugs Standard Control, EG, Drug Control Administration, Reuters, World Health Organization, WHO, Laboratories, World Health Organisation, Fourrts, Pharmaceuticals Export, of India, Thomson Locations: Ramnagar, Jammu, India, DELHI, Gambia, Uzbekistan, Cameroon, Gujarat, Fourrts, Iraq, pharmexcil

Health Minister Mansukh Mandaviya and federal and state regulators attended the session in February, according to a statement from the health ministry that did not mention cough syrups. A source with knowledge of the matter said the policy change could mean increased oversight of India's $41 billion pharmaceutical industry, which is the world's largest supplier of generic medicines. Increased testing of cough syrups as well as of raw materials for drugs in general is one of the steps being considered, said the source. India has acted against a second Indian company whose cough syrups were linked to the deaths of 19 kids in Uzbekistan, including the arrest of three of its employees. Indian health officials have expressed concern that the incidents of contaminated syrups will harm its pharmaceutical industry.

Two Marion directors were "out of the country and will be arrested as soon as they land in India," senior police official Ram Badan Singh told Reuters. Uzbekistan in December said the children died after consuming Marion's cough syrups. The same toxin was found in cough syrups exported to Gambia by another Indian company, Maiden Pharmaceuticals. India in October suspended production at Maiden for violations of manufacturing standards after the World Health Organization said four of its cough syrups may have killed dozens of children in Gambia. The deaths in Gambia and Uzbekistan have dented the image of the $41 billion pharmaceutical industry in India, which is known as the "pharmacy of the world."

The WHO suspects that four of the syrups made by Maiden Pharmaceuticals Limited – Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup – have “unacceptable amounts” of chemicals that can damage the brain, lungs, liver and kidneys of those who take them. The deaths confounded medics until a pattern emerged: dozens of patients younger than five had fallen ill three to five days after taking a locally sold syrup made by Maiden Pharmaceuticals. CNN has reached out to Maiden Pharmaceuticals Limited, but has not yet heard back. All of the children had consumed Maiden Pharmaceuticals’ cough syrups, authorities added. One official told Reuters that the total number of deaths nationwide was “still being determined.”Indonesia’s Food and Drug Monitoring Agency said this week that the cough syrups had not been registered in the country.

Search resuls for: "Central Drugs Standard Control"

4 mentions found